Markets:

Overview

News

Currencies

International

Treasuries

Enanta Pharmaceuticals, Inc. - Common Stock (NQ:ENTA)

13.85 +0.01 (+0.07%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Enanta Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Insights into Enanta Pharma Q4 Earnings ↗

November 25, 2024

Via Benzinga

Enanta Pharma: Q4 Earnings Insights ↗

November 25, 2024

Via Benzinga

Earnings Breakdown: Enanta Pharma Q4 ↗

November 25, 2024

Via Benzinga

Earnings Scheduled For November 25, 2024 ↗

November 25, 2024

Via Benzinga

Enanta Pharma's Earnings Outlook ↗

November 22, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Enanta Pharma Through 4 Analysts ↗

October 09, 2024

Via Benzinga

Recap: Enanta Pharma Q1 Earnings ↗

February 07, 2024

Via Benzinga

Earnings Scheduled For February 7, 2024 ↗

February 07, 2024

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.

Via Benzinga

Earnings Preview For Enanta Pharma ↗

February 06, 2024

Via Benzinga

What 5 Analyst Ratings Have To Say About Enanta Pharma ↗

November 21, 2023

Via Benzinga

Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study ↗

September 26, 2024

Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms while maintaining a favorable safety profile. EDP-323 offers potential as a...

Via Benzinga

ENTA Stock Earnings: Enanta Pharma Beats EPS, Beats Revenue for Q3 2024 ↗

August 05, 2024

ENTA stock results show that Enanta Pharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.

Via InvestorPlace

ENTA Stock Earnings: Enanta Pharma Misses EPS, Beats Revenue for Q2 2024 ↗

May 06, 2024

ENTA stock results show that Enanta Pharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 21, 2023

Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the...

Via Benzinga

Recap: Enanta Pharma Q4 Earnings ↗

November 20, 2023

Via Benzinga

Enanta Pharma Earnings Preview ↗

November 17, 2023

Via Benzinga

Analyst Expectations for Enanta Pharma's Future ↗

October 23, 2023

Via Benzinga

Earnings Scheduled For November 20, 2023 ↗

November 20, 2023

Companies Reporting Before The Bell • Greenland Technologies (NASDAQ:GTEC) is projected to report quarterly earnings at $0.05 per share on revenue of $24.26 million.

Via Benzinga

The Latest Analyst Ratings for Enanta Pharma ↗

September 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 05, 2023

Via Benzinga

Airbnb, Blackstone Rise On News They'll Join S&P 500 Index ↗

September 02, 2023

ABNB and BX will join Sept. 18 as part of a quarterly rebalancing.

Via Investor's Business Daily

Topics Stocks

Enanta Pharma's Earnings: A Preview ↗

August 04, 2023

Via Benzinga

Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 05, 2023

Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform...

Via Benzinga

Why Shares of Enanta Pharmaceuticals Are Dropping Tuesday ↗

August 08, 2023

The company saw a slight revenue decline in its fiscal 2023 third-quarter earnings report.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗

August 08, 2023

Via Benzinga

DraftKings To Rally Over 38%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

August 08, 2023

Piper Sandler raised the price target for Chegg, Inc. (NYSE: CHGG) from $11 to $13. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Chegg shares rose 19.9% to $12.03 in pre-market...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

July 24, 2023

On Monday morning, 70 companies achieved new lows for the year.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 21, 2023

On Friday, 54 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

July 18, 2023

During Tuesday's trading, 46 companies set new 52-week lows.

Via Benzinga

Why Enanta Shares Are Plunging Today ↗

May 09, 2023

Enanta Pharmaceuticals Inc's (NASDAQ: ENTA) investigational COVID-19 pill, EDP-235, met its primary endpoints of safety and tolerability in its Phase 2 SPRINT trial but yielded

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Enanta Pharmaceuticals, Inc. - Common Stock (NQ:ENTA)

Headline News about Enanta Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today